Model DetailsEye - Harderian gland adenoma
Model Name |
Eye - Harderian gland adenoma | Strain |
(C57BL/6 x C3H)F1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
Harderian gland, adenoma • Harderian gland neoplasm • harderian gland adenoma • Harderian gland adenoma |
Strain Synonyms |
B6C3F1 • (C57BL/6xC3H) • F1-hybrid B6C3F1 • B6C3F1 • hybrid B6C3F1 • B6C3F1 (C3H x C57B16) • B6C3F1 hybrid |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Eye - Harderian gland | Unspecified |
observed |
|
Hong HL, Carcinogenesis 1997 Apr;18(4):783-9 | |
| Eye - Harderian gland | Unspecified |
observed |
>2 years |
|
Goodrow TL, Carcinogenesis 1994 Nov;15(11):2665-7 |
| Eye - Harderian gland | Female |
observed |
103 weeks |
|
Fred C, Cancer Res 2008 Oct 1;68(19):8014-21 |
| Eye - Harderian gland | Male |
1.0% (2 of 200 mice) |
|
Chandra M, Toxicol Lett 1992 Jan;60(1):91-8 | |
| Eye - Harderian gland | Female |
15.5% (31 of 200 mice) |
|
Chandra M, Toxicol Lett 1992 Jan;60(1):91-8 | |
| Eye - Harderian gland | Male |
4.7% (64 of 1355 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Male |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Male |
18% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Male |
5.4% (59 of 1100 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Male |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Male |
18% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Female |
3.3% (45 of 1353 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Female |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Female |
10% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Female |
3.1% (34 of 1092 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Female |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Female |
16% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Eye - Harderian gland | Male |
2.1% (50 of 2343 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Eye - Harderian gland | Female |
1.3% (32 of 2486 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |